Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001450324-21-000007

CEO & President acquired 9,146 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

EQUELS THOMAS K. · CEO & President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-11-17 Grant or award : show line 1 in the form +9,146 $1.64 $14,999 234,401 D
Loading xslF345X03/primary_doc.xml…